Effects of physical endurance training on the plasma renin-angiotensin-aldosterone system in normal man. 1988

P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
Department of Pathophysiology, University Hospital Gasthuisberg, University of Leuven, Belgium.

The effect of physical endurance training on the plasma renin-angiotensin-aldosterone system was studied in 27 normal sedentary volunteers aged between 20 and 55 years, using a randomized two-period cross-over study design. After 4 months of training (2.5 h/week), peak oxygen uptake and physical working capacity at a heart rate of 130 beats/min were increased by 16% (P less than 0.01) and 29% (P less than 0.001) respectively, whereas resting heart rate was decreased by 15% (P less than 0.001). The plasma noradrenaline concentration and haematocrit were both decreased (P less than 0.01) after training. For the total group of subjects, the small decreases in plasma renin activity (PRA) and in the plasma concentrations of angiotensin-I, angiotensin-II and aldosterone were not statistically significant. However, the change in PRA during the training period was negatively correlated with the increase in physical working capacity (r = -0.49, P less than 0.01), suggesting that PRA decreased only in those subjects with the greatest increase in exercise capacity. Also, the change in plasma aldosterone during training was negatively related to the rise in physical working capacity (r = -0.57, P less than 0.01). Furthermore, the changes in plasma angiotensin-I (r = 0.75), angiotensin-II (r = 0.49) and aldosterone (r = 0.43) during the training period correlated positively with the change in PRA. It is concluded that physical endurance training, leading to a substantial gain of physical working capacity, suppresses the plasma renin-angiotensin-aldosterone system in normal man.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010806 Physical Education and Training Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY. Education, Physical,Physical Education,Physical Education, Training
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
October 1965, Connecticut medicine,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
October 1981, Journal of clinical pharmacology,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
April 1984, American heart journal,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
June 1975, Clinical science and molecular medicine. Supplement,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
December 1979, The Journal of clinical endocrinology and metabolism,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
April 1979, The Journal of clinical investigation,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
September 1993, The Journal of sports medicine and physical fitness,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
November 2020, Endocrine journal,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
November 1976, Die Medizinische Welt,
P Hespel, and P Lijnen, and R Van Hoof, and R Fagard, and W Goossens, and W Lissens, and E Moerman, and A Amery
May 1983, Research communications in chemical pathology and pharmacology,
Copied contents to your clipboard!